Issue link: https://www.e-digitaleditions.com/i/1546950
36 OctOber 2026 Inhalation DPI development and manufacturing services Experic's experienced team provides customized spray drying, precision filling, analytical support and pack- aging solutions at clinical and commercial scale for reservoir and single-dose dry powder inhalation (DPI) products. From formulation development and GMP manufacturing in low humidity environments to clin- ical trial supplies and global logistics, Experic offers services that can solve development and manufactur- ing challenges, accelerate time to market, and mitigate risk for inhalation products with a range of properties. Experic, LLC US: +1 609 537-4040 www.expericservices.com DPI and nasal delivery formulation, device and manufacturing Hovione provides specialist expertise and leadership in particle engineering and formulation development to ensure that your inhalation and nasal therapies are engi- neered for success from start to finish. Fully integrated in one site, Hovione offers simple, patented and globally competitive dry powder inhalers— disposable, capsule, blister, large dose and high performance DPIs—which are available for fully integrated, turnkey development with formulation and for licensing. Expanding our inhalation offering, Hovione provides advanced nasal powder delivery devices, designed for local, systemic and nose-to-brain applications. Hovione—Delivering solutions, every breath of the way. Hovione Portugal: +351 21 982 9000 hovione.com/contact-us www.hovione.com Pharmaceutical development and GMP laboratory capabilities e transition to low global warming potential (GWP) propellants presents significant development and ana- lytical challenges for pMDI manufacturers. Brough- ton can support pharmaceutical companies navigating reformulation to next-generation propellants such as HFA-152a and HFO-1234ze(E), providing analyt- ical expertise throughout the product lifecycle. Our capabilities include analytical method development, validation and transfer, stability studies, extractables and leachables assessment, toxicology services and QC testing. Broughton can also support the evaluation of formulation, container-closure and material compati- bility as manufacturers assess the impact of propellant changes on product performance. Combining phar- maceutical development expertise with GMP labora- tory capabilities, Broughton provides flexible, tailored support for next-generation inhalation programs. Broughton UK: +44 1282 570524 wsilver@broughton-group.com www.broughton-group.com New US patent for enhanced pMDI ferrule MKON, LLC is an engineering design firm with extensive experience in product and package design. e company's principal engineers have more than twenty-five patents. e newest patent is for an enhanced pMDI ferrule. e design reduces ferrule material weight while offering the ability to use spe- cialized inspection equipment to quickly monitor individual canister leakage, rejecting those that fail pre-determined leakage values. Using the enhanced ferrule and unique inspection system can help avoid lengthy batch storage, manual inspection and poten- tial batch rejection that may be experienced with current weight loss methods. MKON has a proven track record for identifying problems and engineering innovative solutions for clients. Contact us today. MKON, LLC US: +1 512 707-9260 simon.freed@mkonllc.com www.mkonllc.com

